Rui Sun
Harbin Medical University(CN)Shanghai Jiao Tong University(CN)Nankai University(CN)Ruijin Hospital(CN)Zhengzhou University(CN)Suzhou Municipal Hospital(CN)Suzhou Traditional Chinese Medicine Hospital(CN)Henan Cancer Hospital(CN)Shanghai Institute of Hematology(CN)Qilu Hospital of Shandong University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Genetic Associations and Epidemiology, Bioinformatics and Genomic Networks, Lymphoma Diagnosis and Treatment, Cancer-related molecular mechanisms research
Most-Cited Works
- → Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma(2019)153 cited
- → Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China(2015)79 cited
- → Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome(2021)70 cited
- → A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer(2020)61 cited
- → Modified Paclitaxel-loaded Nanoparticles for Inhibition of Hyperplasia in a Rabbit Arterial Balloon Injury Model(2007)40 cited
- → Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation